TD Cowen Initiates Coverage on Senseonics (NYSE:SENS)

Investment analysts at TD Cowen began coverage on shares of Senseonics (NYSE:SENS - Get Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm set a "buy" rating and a $1.25 price target on the stock. TD Cowen's target price suggests a potential upside of 115.55% from the company's previous close.

SENS has been the subject of a number of other reports. HC Wainwright restated a "buy" rating and set a $1.40 price target (up from $1.10) on shares of Senseonics in a report on Tuesday, July 8th. Wall Street Zen raised shares of Senseonics to a "sell" rating in a report on Monday, May 12th. Finally, Mizuho started coverage on shares of Senseonics in a report on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price target for the company.

Senseonics Price Performance

Shares of NYSE:SENS traded up $0.02 on Tuesday, reaching $0.58. 11,793,008 shares of the company traded hands, compared to its average volume of 8,649,176. The company's 50 day moving average is $0.52 and its 200-day moving average is $0.68. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. Senseonics has a fifty-two week low of $0.25 and a fifty-two week high of $1.40. The stock has a market capitalization of $379.38 million, a PE ratio of -4.46 and a beta of 0.92.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Raymond James Financial Inc. bought a new position in shares of Senseonics during the fourth quarter valued at about $26,000. IFP Advisors Inc lifted its position in shares of Senseonics by 120.9% during the first quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after purchasing an additional 26,000 shares in the last quarter. CTC Alternative Strategies Ltd. bought a new position in shares of Senseonics during the first quarter valued at about $31,000. HighTower Advisors LLC bought a new position in shares of Senseonics during the fourth quarter valued at about $32,000. Finally, Two Sigma Investments LP bought a new position in shares of Senseonics during the fourth quarter valued at about $36,000. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.